CORONA Remedies Announces 22nd AGM, Record Date for Dividend, and E-voting
CORONA Remedies Limited announced its 22nd Annual General Meeting. The notice includes the record date for dividend and e-voting information. Advertisements were published on June 16, 2026, in Financial Express (English and Gujarati) and are available on the company website.
This is a standard procedural announcement for an upcoming AGM. It does not involve any new financial outcomes, strategic shifts, or significant corporate actions that would materially impact the company's valuation or operations in the short term.
The announcement is a routine corporate communication regarding the AGM and related procedures. It does not contain any new financial information or strategic developments that would indicate a positive or negative sentiment.
CORONA Remedies Limited has announced the details for its 22nd Annual General Meeting (AGM). The company has published a notice regarding the AGM, including the intimation of the record date for dividend distribution and information pertaining to e-voting. These advertisements were published in the Financial Express (English) and Financial Express (Gujarati) editions on June 16, 2026.
The company has also made this information available on its official website, www.coronaremedies.com, for shareholders to access.
This announcement serves as a formal notification to the regulatory bodies, including the BSE Limited and the National Stock Exchange of India Limited, regarding these important corporate events.
What to do with a filing like this
CORONA Remedies Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CORONA Remedies Limited. Read the original for the full detail.